Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption
Clinical trial NCT05232942 · UNKNOWN
Trial details
- NCT number
- NCT05232942
- Sponsor
- Hospital Clínico Universitario de Valladolid
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-15
- Primary completion
- 2024-02-15
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.